Advanced search
Publication Cover
Gut Microbes Volume 11, 2020 - Issue 4
Submit an article Journal homepage
4,241
Views
28
CrossRef citations to date
0
Altmetric
Research Paper/Report

Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota

Vishal Singha Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA, USAView further author information
,
Beng San Yeohb Microbiome Consortium, Center for Hypertension and Precision Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA;c Department of Physiology & Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USAORCID Iconhttps://orcid.org/0000-0002-7723-8733View further author information
ORCID Icon,
Ahmed A. Abokorb Microbiome Consortium, Center for Hypertension and Precision Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA;c Department of Physiology & Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USAView further author information
,
Rachel M. Golonkab Microbiome Consortium, Center for Hypertension and Precision Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA;c Department of Physiology & Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USAView further author information
,
Yuan Tiand Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, USAORCID Iconhttps://orcid.org/0000-0001-6174-3359View further author information
ORCID Icon,
Andrew D. Pattersond Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, USAORCID Iconhttps://orcid.org/0000-0003-2073-0070View further author information
ORCID Icon,
Bina Joeb Microbiome Consortium, Center for Hypertension and Precision Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA;c Department of Physiology & Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USAView further author information
,
Mathias Heikenwaldere Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, GermanyView further author information
&
Matam Vijay-Kumarb Microbiome Consortium, Center for Hypertension and Precision Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA;c Department of Physiology & Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USACorrespondence[email protected]
View further author information
 show all
Pages 1077-1091 | Received 24 Oct 2019, Accepted 28 Feb 2020, Published online: 30 Mar 2020

Citations (28)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jayashi Rajapakse, Saroj Khatiwada, Anna Camille Akon, Kin Lam Yu, Sj Shen & Amany Zekry. (2023) Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions. Gut Microbes 15:2.
Read now
Yaolian Hu, Jun He, Ping Zheng, Xiangbing Mao, Zhiqing Huang, Hui Yan, Yuheng Luo, Jie Yu, Junqiu Luo, Bing Yu & Daiwen Chen. (2023) Prebiotic inulin as a treatment of obesity related nonalcoholic fatty liver disease through gut microbiota: a critical review. Critical Reviews in Food Science and Nutrition 63:7, pages 862-872.
Read now

Articles from other publishers (26)

Yoshiaki Sugiyama, Kenta Yamamoto, Takashi Honda, Asuka Kato, Hisanori Muto, Shinya Yokoyama, Takanori Ito, Norihiro Imai, Yoji Ishizu, Masanao Nakamura, Tomomi Asano, Atsushi Enomoto, Kei Zaitsu, Masatoshi Ishigami, Mitsuhiro Fujishiro & Hiroki Kawashima. (2023) Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis. Hepatology International 17:6, pages 1378-1392.
Crossref
Beng San Yeoh, Rachel M Golonka, Piu Saha, Mrunmayee R Kandalgaonkar, Yuan Tian, Islam Osman, Andrew D Patterson, Andrew T Gewirtz, Bina Joe & Matam Vijay-Kumar. (2023) Urine-based Detection of Congenital Portosystemic Shunt in C57BL/6 Mice. Function 4:5.
Crossref
Rachel Newsome, Ye Yang & Christian Jobin. (2023) Western diet influences on microbiome and carcinogenesis. Seminars in Immunology 67, pages 101756.
Crossref
Qiqing Yang, Bin Wang, Qinghui Zheng, Heyu Li, Xuli Meng, Fangfang Zhou & Long Zhang. (2023) A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy. Advanced Science 10:15.
Crossref
Ze Xiang, Jian Wu, Jiarui Li, Shusen Zheng, Xuyong Wei & Xiao Xu. (2023) Gut Microbiota Modulation: A Viable Strategy to Address Medical Needs in Hepatocellular Carcinoma and Liver Transplantation. Engineering.
Crossref
Chen Chen, Zehua Wang, Yi Ding & Yanru Qin. (2023) Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Frontiers in Immunology 14.
Crossref
Rachel M. Golonka, Beng San Yeoh, Piu Saha, Amira Gohara, Ramakumar Tummala, Stanislaw Stepkowski, Amit K. Tiwari, Bina Joe, Frank J. Gonzalez, Andrew T. Gewirtz & Matam Vijay-Kumar. (2023) Loss of toll-like receptor 5 potentiates spontaneous hepatocarcinogenesis in farnesoid X receptor–deficient mice. Hepatology Communications 7:6.
Crossref
Bhrigu Kumar Das. (2022) Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings. APMIS 130:12, pages 719-740.
Crossref
Veda Gokula, David Terrero & Bina Joe. (2022) Six Decades of History of Hypertension Research at the University of Toledo: Highlighting Pioneering Contributions in Biochemistry, Genetics, and Host-Microbiota Interactions. Current Hypertension Reports 24:12, pages 669-685.
Crossref
Shawn Lu Wen Tan, Erez Israeli, Russell E. Ericksen, Pierce K.H. Chow & Weiping Han. (2022) The altered lipidome of hepatocellular carcinoma. Seminars in Cancer Biology 86, pages 445-456.
Crossref
Lihong Fu, Yihan Qian, Zhi Shang, Xuehua Sun, Xiaoni Kong & Yueqiu Gao. (2022) Antibiotics enhancing drug-induced liver injury assessed for causality using Roussel Uclaf Causality Assessment Method: Emerging role of gut microbiota dysbiosis. Frontiers in Medicine 9.
Crossref
Yang Liu, Xin Zhang, Shuo Chen, Jiazhong Wang, Shuo Yu, Yiming Li, Meng Xu, Harouna Aboubacar, Junhui Li, Tao Shan, Jixin Wang & Gang Cao. (2022) Gut-derived lipopolysaccharide promotes alcoholic hepatosteatosis and subsequent hepatocellular carcinoma by stimulating neutrophil extracellular traps through toll-like receptor 4. Clinical and Molecular Hepatology 28:3, pages 522-539.
Crossref
Imaad Said, Hassan Ahad & Adnan Said. (2022) Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics. World Journal of Gastrointestinal Oncology 14:5, pages 947-958.
Crossref
Yu Wu, Chenyang Wu, Yanyun Che, Tao Zhang, Chen Dai, Audrey D. Nguyễn, Kun Duan, Yanyu Huang, Nannan Li, Hui Zhou, Xin Wan, Yuedi Wang, Hongjun Lei, Ping Hao, Caiyue Li & Yi Wu. (2022) Effects of Glycyrrhiza Polysaccharides on Chickens' Intestinal Health and Homeostasis. Frontiers in Veterinary Science 9.
Crossref
Chenchun Chen, Peng Tang, Jun Liang, Dongping Huang, Dongxiang Pan, Mengrui Lin, Li Wu, Huanni Wei, Huishen Huang, Yonghong Sheng, Yanye Song, Bincai Wei, Qian Liao, Shun Liu & Xiaoqiang Qiu. (2022) Association between Intrauterine Microbiome and Risk of Intrauterine Growth Restriction: A Case-Control Study Based on Guangxi Zhuang Birth Cohort in China. The Tohoku Journal of Experimental Medicine 258:1, pages 11-21.
Crossref
Rong Yang & Li Qian. (2022) Research on Gut Microbiota-Derived Secondary Bile Acids in Cancer Progression. Integrative Cancer Therapies 21, pages 153473542211141.
Crossref
Geicho Nakatsu. (2021) Toward a postbiotic era of microbiome science: Opportunities to advance immunotherapies for hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 37:1, pages 34-38.
Crossref
Ilenia Bartolini, Matteo Risaliti, Rosaria Tucci, Paolo Muiesan, Maria Novella Ringressi, Antonio Taddei & Amedeo Amedei. (2021) Gut microbiota and immune system in liver cancer: Promising therapeutic implication from development to treatment. World Journal of Gastrointestinal Oncology 13:11, pages 1616-1631.
Crossref
Emily Payne, Kylee Harrington, Philomena Richard, Rebecca Brackin, Ravin Davis, Sarah Couture, Jacob Liff, Francesca Asmus, Elizabeth Mutina, Anyssa Fisher, Denise Giuvelis, Sebastien Sannajust, Bahman Rostama, Tamara King, Lisa M. Mattei, Jung-Jin Lee, Elliot S Friedman, Kyle Bittinger, Meghan May & Glenn W. Stevenson. (2021) Effects of Vancomycin on Persistent Pain-Stimulated and Pain-Depressed Behaviors in Female Fischer Rats With or Without Voluntary Access to Running Wheels. The Journal of Pain 22:11, pages 1530-1544.
Crossref
Wendy Lin, Ana Djukovic, Deepti Mathur & Joao B Xavier. (2021) Listening in on the conversation between the human gut microbiome and its host. Current Opinion in Microbiology 63, pages 150-157.
Crossref
Guofeng Ji, Xinghui Si, Si Dong, Yajun Xu, Mingqiang Li, Bo Yang, Zhaohui Tang, Xuedong Fang, Leaf Huang, Wantong Song & Xuesi Chen. (2021) Manipulating Liver Bile Acid Signaling by Nanodelivery of Bile Acid Receptor Modulators for Liver Cancer Immunotherapy. Nano Letters 21:16, pages 6781-6791.
Crossref
Shuli Man, Taohua Liu, Yuan Yao, Yingying Lu, Long Ma & Fuping Lu. (2021) Friend or foe? The roles of inulin-type fructans. Carbohydrate Polymers 252, pages 117155.
Crossref
Liwei Wu, Jiao Feng, Jingjing Li, Qiang Yu, Jie Ji, Jianye Wu, Weiqi Dai & Chuanyong Guo. (2021) The gut microbiome-bile acid axis in hepatocarcinogenesis. Biomedicine & Pharmacotherapy 133, pages 111036.
Crossref
Rachel M. Golonka & Matam Vijay-Kumar. 2021. Mechanisms and Therapy of Liver Cancer. Mechanisms and Therapy of Liver Cancer 171 255 .
Mira J. Pauly, Julia K. Rohde, Clara John, Ioannis Evangelakos, Anja Christina Koop, Paul Pertzborn, Klaus Tödter, Ludger Scheja, Joerg Heeren & Anna Worthmann. (2020) Inulin Supplementation Disturbs Hepatic Cholesterol and Bile Acid Metabolism Independent from Housing Temperature. Nutrients 12:10, pages 3200.
Crossref
Chunye Zhang, Ming Yang & Aaron C. Ericsson. (2020) The Potential Gut Microbiota-Mediated Treatment Options for Liver Cancer. Frontiers in Oncology 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.